Viewing StudyNCT00145171



Ignite Creation Date: 2024-05-05 @ 11:49 AM
Last Modification Date: 2024-10-26 @ 9:14 AM
Study NCT ID: NCT00145171
Status: COMPLETED
Last Update Posted: 2005-09-05
First Post: 2005-09-02

Brief Title: A Sub-Study With Patients in APO401 to Evaluate Adverse Events During Dose Introduction in Apomorphine-naïve Patients
Sponsor: Mylan Bertek Pharmaceuticals
Organization: Mylan Bertek Pharmaceuticals

Key Dates - Follows AllAPIJSON File Order

Start Date: 2001-02
Start Date Type: None
Primary Completion Date: None
Primary Completion Date Type: None
Completion Date: 2002-08
Completion Date Type: None
First Submit Date: 2005-09-02
First Submit QC Date: September 2 2005
Study First Post Date: 2005-09-05
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2005-09-02
Last Update Post Date: 2005-09-05
Last Update Post Date Type: ESTIMATED